FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Ozempic

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberK082347
Where it was soldFL, GA, SC
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byNovo Nordisk A/S DK-2880 Bagsvaerd, Denmark
Brand nameOZEMPIC
Generic nameORAL SEMAGLUTIDE
Active ingredient(s)SEMAGLUTIDE
Distributed by / forCardinal Health Inc.
NDC0169-4307-13
Show the full FDA record
Full product labelRybelsus (semaglutide) Tablets 7 mg Once daily Each tablet contains 7 mg semaglutide 30 tablets 3 blister packs. Each pack contains 10 tablets. Rx only NDC 0169-4307-13 Manufactured by: Novo Nordisk A/S DK-2880 Bagsvaerd, Denmark
Recalling firmCardinal Health Inc.
DistributionFL, GA, SC
Quantity1189 cartons
Recall initiated2021-03-15
Report date2021-06-02
Recall completed2024-06-17
Recall numberD-0536-2021
ClassificationClass II
FDA statusTerminated
Origin on fileDublin OH United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.